SQUEEZE project
@squeezeproject.bsky.social
Horizon Europe-funded consortium that aims to improve Rheumatoid Arthritis care through precision medicine, patient-centered approaches, and optimizing existing treatments led by @danielaletaha.bsky.social at @meduniwien.ac.at
Reposted by SQUEEZE project
Last month was particularly busy for our Division’s research, with a broad range of studies published across rheumatology and related fields. In case you missed them, here’s a recap, from biomarkers and ultrasound in rheumatoid arthritis to Sjögren disease, vaccination, and D2T RA:
September 10, 2026 at 9:17 AM
Last month was particularly busy for our Division’s research, with a broad range of studies published across rheumatology and related fields. In case you missed them, here’s a recap, from biomarkers and ultrasound in rheumatoid arthritis to Sjögren disease, vaccination, and D2T RA:
🧪 Can tiny amounts of blood help us understand treatment response in #RA? Our latest SQUEEZE study shows that Torque Teno Virus levels can be measured reliably even in small serum samples – an important step towards using large biobanks for future biomarker research. 🔬 www.mdpi.com/2076-3271/14...
www.mdpi.com
August 13, 2026 at 12:17 PM
🧪 Can tiny amounts of blood help us understand treatment response in #RA? Our latest SQUEEZE study shows that Torque Teno Virus levels can be measured reliably even in small serum samples – an important step towards using large biobanks for future biomarker research. 🔬 www.mdpi.com/2076-3271/14...
Congratulations to the @bonellilab.bsky.social on this work on understanding how patients respond to MTX in the first weeks. Proud that members of SQUEEZE contributed to this work, which aligns closely with our mission of optimising treatment selection in #RA. linkinghub.elsevier.com/retrieve/pii...
Redirecting
linkinghub.elsevier.com
July 28, 2026 at 3:22 PM
Congratulations to the @bonellilab.bsky.social on this work on understanding how patients respond to MTX in the first weeks. Proud that members of SQUEEZE contributed to this work, which aligns closely with our mission of optimising treatment selection in #RA. linkinghub.elsevier.com/retrieve/pii...
New in "Rheumatology": analysis of 64 clinical trials creates a standardised "safety gestalt" for #RA treatments. Same serious side effect rates across drugs, but each has its own safety pattern - helping doctors choose the best fit for each patient. #RheumatoidArthritis doi.org/10.1093/rheu...
July 2, 2026 at 9:36 AM
New in "Rheumatology": analysis of 64 clinical trials creates a standardised "safety gestalt" for #RA treatments. Same serious side effect rates across drugs, but each has its own safety pattern - helping doctors choose the best fit for each patient. #RheumatoidArthritis doi.org/10.1093/rheu...
Learn more about the SQUEEZE project in our most recent newsletter edition, accessible via LinkedIn: www.linkedin.com/pulse/squeez... #RheumatoidArthritis #RA #EUprojects #HorizonEurope
SQUEEZE newsletter - issue no6
Let's squeeze the best out of existing treatments in rheumatoid arthritis (RA). Welcome to the sixth issue of our bi-annual SQUEEZE newsletter - and what a busy half-year this has been! From a major r...
www.linkedin.com
June 30, 2026 at 4:49 AM
Learn more about the SQUEEZE project in our most recent newsletter edition, accessible via LinkedIn: www.linkedin.com/pulse/squeez... #RheumatoidArthritis #RA #EUprojects #HorizonEurope
Reposted by SQUEEZE project
Reposted by SQUEEZE project
The #stakeholder engagement strategy of the #SQUEEZE project was showcased at the Spanish and Portuguese Epidemiology Congress #SEE2026 #APE2026 in Pamplona.
See below a summary in Spanish!
@squeezeproject.bsky.social
See below a summary in Spanish!
@squeezeproject.bsky.social
June 29, 2026 at 7:27 AM
The #stakeholder engagement strategy of the #SQUEEZE project was showcased at the Spanish and Portuguese Epidemiology Congress #SEE2026 #APE2026 in Pamplona.
See below a summary in Spanish!
@squeezeproject.bsky.social
See below a summary in Spanish!
@squeezeproject.bsky.social
Reposted by SQUEEZE project
What a fantastic #EULAR2026 in London! Proud of the outstanding scientific contributions from our Division of Rheumatology @meduniwien.ac.at, from talks, posters and chairing to leadership in key sessions. Great visibility also for @squeezeproject.bsky.social and @autopix.bsky.social!
June 15, 2026 at 6:46 AM
What a fantastic #EULAR2026 in London! Proud of the outstanding scientific contributions from our Division of Rheumatology @meduniwien.ac.at, from talks, posters and chairing to leadership in key sessions. Great visibility also for @squeezeproject.bsky.social and @autopix.bsky.social!
While in SQUEEZE we are researching Torque Teno Virus in #RA, a European team of nephrologists also led by @meduniwien.ac.at has recently shared first results on their investigator-intiated, multicentre, patient+central assessor-blinded, non-inferiority, randomized controlled phase II trial on #TTV.
Successful trial ✅️
An international team coordinated by #MedUniVienna demonstrated in a #clinicaltrial that #TorqueTenovirus-guided dosing of #immunosuppressants in #kidneytransplant recipients is safe.
More about the @ttvguidetx.bsky.social study coordinated by @gregorbond.bsky.social! ⬇️
An international team coordinated by #MedUniVienna demonstrated in a #clinicaltrial that #TorqueTenovirus-guided dosing of #immunosuppressants in #kidneytransplant recipients is safe.
More about the @ttvguidetx.bsky.social study coordinated by @gregorbond.bsky.social! ⬇️
Biomarker-guided immunosuppression following kidney transplantation successfully tested
Further details!
www.meduniwien.ac.at
June 8, 2026 at 12:49 PM
While in SQUEEZE we are researching Torque Teno Virus in #RA, a European team of nephrologists also led by @meduniwien.ac.at has recently shared first results on their investigator-intiated, multicentre, patient+central assessor-blinded, non-inferiority, randomized controlled phase II trial on #TTV.
While #EULAR2026 is slowly coming to an end, there's still more interesting contributions happening today. Join @simonsteiger.bsky.social and @nilssteinz.bsky.social at the poster view session starting at 10:15 am BST. 👇👇👇
June 6, 2026 at 7:45 AM
While #EULAR2026 is slowly coming to an end, there's still more interesting contributions happening today. Join @simonsteiger.bsky.social and @nilssteinz.bsky.social at the poster view session starting at 10:15 am BST. 👇👇👇
Reposted by SQUEEZE project
Katy Antonopoulou shows a clear care gap:
The rheumatologist may focus on RMD medication and disease activity.
The gynaecologist/menopause specialist may focus on menopause symptoms.
But the patient falls in the middle.
That gap needs to close.
#EULAR2026
The rheumatologist may focus on RMD medication and disease activity.
The gynaecologist/menopause specialist may focus on menopause symptoms.
But the patient falls in the middle.
That gap needs to close.
#EULAR2026
June 5, 2026 at 2:26 PM
Katy Antonopoulou shows a clear care gap:
The rheumatologist may focus on RMD medication and disease activity.
The gynaecologist/menopause specialist may focus on menopause symptoms.
But the patient falls in the middle.
That gap needs to close.
#EULAR2026
The rheumatologist may focus on RMD medication and disease activity.
The gynaecologist/menopause specialist may focus on menopause symptoms.
But the patient falls in the middle.
That gap needs to close.
#EULAR2026
Reposted by SQUEEZE project
Katy Antonopoulou’s recommendations to the clinical community are clear:
Ask about menopause.
Refer proactively.
Reassure and inform patients.
Work with patient associations. Advocate for multidisciplinary menopause-RMD clinics.
#EULAR2026
Ask about menopause.
Refer proactively.
Reassure and inform patients.
Work with patient associations. Advocate for multidisciplinary menopause-RMD clinics.
#EULAR2026
June 5, 2026 at 2:32 PM
Katy Antonopoulou’s recommendations to the clinical community are clear:
Ask about menopause.
Refer proactively.
Reassure and inform patients.
Work with patient associations. Advocate for multidisciplinary menopause-RMD clinics.
#EULAR2026
Ask about menopause.
Refer proactively.
Reassure and inform patients.
Work with patient associations. Advocate for multidisciplinary menopause-RMD clinics.
#EULAR2026
Definitely one of our #EULAR2026 highlights: a very SQUEEZE-heavy line-up at the session "Please mind the gap: Approaches to implementing research into rheumatology practice" with @agneskocher2.bsky.social, @sabinadegeest.bsky.social, @estitxuloza.bsky.social & our patient research partner Ria. 💙👩👩🦱👩🦰
June 5, 2026 at 5:21 PM
Definitely one of our #EULAR2026 highlights: a very SQUEEZE-heavy line-up at the session "Please mind the gap: Approaches to implementing research into rheumatology practice" with @agneskocher2.bsky.social, @sabinadegeest.bsky.social, @estitxuloza.bsky.social & our patient research partner Ria. 💙👩👩🦱👩🦰
Full house at the poster tour of SQUEEZE expert Karolina Anderle from @meduniwien.ac.at on Day 3 of #EULAR2026! Karolina presented the determinants of methotrexate polyglutamate levels, the monitoring of which pose a great potential for personalised optimisation in MTX therapy.
June 5, 2026 at 1:43 PM
Full house at the poster tour of SQUEEZE expert Karolina Anderle from @meduniwien.ac.at on Day 3 of #EULAR2026! Karolina presented the determinants of methotrexate polyglutamate levels, the monitoring of which pose a great potential for personalised optimisation in MTX therapy.
Please help us by completing this survey on the availability, accessibility & affordability of #RA treatments across Europe. The results will help identify disparities in the treatment access across Europe & support future evidence-based recommendations for more equitable care. #EULAR2026
June 5, 2026 at 7:59 AM
Please help us by completing this survey on the availability, accessibility & affordability of #RA treatments across Europe. The results will help identify disparities in the treatment access across Europe & support future evidence-based recommendations for more equitable care. #EULAR2026
Time flies and it's already Day3 at #EULAR2026 where today at 9 am BST we will join a workshop led by @autopix.bsky.social on Stakeholder Involvement in EU-funded research. The workshop will be focusing on interactions with policymakers, regulators, and authorities. Very excited to meet everyone!
June 5, 2026 at 7:13 AM
Time flies and it's already Day3 at #EULAR2026 where today at 9 am BST we will join a workshop led by @autopix.bsky.social on Stakeholder Involvement in EU-funded research. The workshop will be focusing on interactions with policymakers, regulators, and authorities. Very excited to meet everyone!
Therapy (DMARD) adherence is often poorly measured, that's why SQUEEZE developed a Care Model to improve adherence. This ehealth facilitated Model is being piloted in Switzerland with the goal to enhance routine rheumatological care. #EULAR2026 @agneskocher2.bsky.social @sabinadegeest.bsky.social
June 4, 2026 at 2:59 PM
Therapy (DMARD) adherence is often poorly measured, that's why SQUEEZE developed a Care Model to improve adherence. This ehealth facilitated Model is being piloted in Switzerland with the goal to enhance routine rheumatological care. #EULAR2026 @agneskocher2.bsky.social @sabinadegeest.bsky.social
Our patient research partner Ria Brokken shares learnings of her work as a patient partner in the implementation of research into Rheumatology practice at #EULAR2026. We are lucky to have a full patient research panel supporting us in our clinical trials & the development of the SQUEEZE Care Model 💙
June 4, 2026 at 2:52 PM
Our patient research partner Ria Brokken shares learnings of her work as a patient partner in the implementation of research into Rheumatology practice at #EULAR2026. We are lucky to have a full patient research panel supporting us in our clinical trials & the development of the SQUEEZE Care Model 💙
Why do promising healthcare innovations often fail to reach patients? 🤔 Today, SQUEEZE contributes to "Please mind the gap: Approaches to implementing research into Rheumatology Practice" starting 2:45 pm with talks on patient engagement & implementation science #EULAR2026 @agneskocher2.bsky.social
June 4, 2026 at 1:01 PM
Why do promising healthcare innovations often fail to reach patients? 🤔 Today, SQUEEZE contributes to "Please mind the gap: Approaches to implementing research into Rheumatology Practice" starting 2:45 pm with talks on patient engagement & implementation science #EULAR2026 @agneskocher2.bsky.social
Did you notice the large crowd of people in the NPO area last night just before the networking dinner at #EULAR2026? There's heaps of passionate clinicians, scientists, HCP, & patients involved in a large number of EU consortia like SQUEEZE - come by at booth **O17** and learn more about our work!
June 4, 2026 at 10:16 AM
Did you notice the large crowd of people in the NPO area last night just before the networking dinner at #EULAR2026? There's heaps of passionate clinicians, scientists, HCP, & patients involved in a large number of EU consortia like SQUEEZE - come by at booth **O17** and learn more about our work!
Still wondering what SQUEEZE does? Learn more about our work in this @ec.europa.eu Horizon Magazine article: projects.research-and-innovation.ec.europa.eu/en/horizon-m... Intrigued? Come visit us at booth 📍O17 in the NPO section of #EULAR2026.
Squeezing more from arthritis drugs to help patients live better
Over the past two decades, a wave of new drug treatments for rheumatoid arthritis (RA) has allowed many people to live free from pain, joint swelling and long-term disability. But for many patients in...
projects.research-and-innovation.ec.europa.eu
June 4, 2026 at 5:38 AM
Still wondering what SQUEEZE does? Learn more about our work in this @ec.europa.eu Horizon Magazine article: projects.research-and-innovation.ec.europa.eu/en/horizon-m... Intrigued? Come visit us at booth 📍O17 in the NPO section of #EULAR2026.
At #EULAR2026, we recently presented the SQUEEZE experience at the PARE poster tour: a 3-year study developing, implementing and evaluating a stakeholder involvement strategy for a complex multinational RA research project, including patients, clinicians, researchers and other end users.
June 3, 2026 at 3:35 PM
At #EULAR2026, we recently presented the SQUEEZE experience at the PARE poster tour: a 3-year study developing, implementing and evaluating a stakeholder involvement strategy for a complex multinational RA research project, including patients, clinicians, researchers and other end users.
Shout out to our neighbours over at @mdr-ra-project.bsky.social - some of us might get confused these days at #EULAR2026 with all the EU consortia we are involved in. 🤪 We trust though that more collaboration will only lead to more learnings, better understanding & better lives for patients with #RA
June 3, 2026 at 3:24 PM
Shout out to our neighbours over at @mdr-ra-project.bsky.social - some of us might get confused these days at #EULAR2026 with all the EU consortia we are involved in. 🤪 We trust though that more collaboration will only lead to more learnings, better understanding & better lives for patients with #RA
🔔 Don't miss our first contribution at #EULAR2026! Estibaliz Loza Santamaria, @inmusc.bsky.social presents the SQUEEZE experience on stakeholder involvement in a multinational research project:
📍PARE Poster Tour
🕓 16:18 BST
Because meaningful research is stronger when stakeholders help shape it.💙
📍PARE Poster Tour
🕓 16:18 BST
Because meaningful research is stronger when stakeholders help shape it.💙
June 3, 2026 at 2:18 PM
🔔 Don't miss our first contribution at #EULAR2026! Estibaliz Loza Santamaria, @inmusc.bsky.social presents the SQUEEZE experience on stakeholder involvement in a multinational research project:
📍PARE Poster Tour
🕓 16:18 BST
Because meaningful research is stronger when stakeholders help shape it.💙
📍PARE Poster Tour
🕓 16:18 BST
Because meaningful research is stronger when stakeholders help shape it.💙